These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17189429)

  • 1. Reduced levels of ATF-2 predispose mice to mammary tumors.
    Maekawa T; Shinagawa T; Sano Y; Sakuma T; Nomura S; Nagasaki K; Miki Y; Saito-Ohara F; Inazawa J; Kohno T; Yokota J; Ishii S
    Mol Cell Biol; 2007 Mar; 27(5):1730-44. PubMed ID: 17189429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
    Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
    Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.
    Zhang M; Shi Y; Magit D; Furth PA; Sager R
    Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence.
    Tront JS; Hoffman B; Liebermann DA
    Cancer Res; 2006 Sep; 66(17):8448-54. PubMed ID: 16951155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating maspin in breast cancer progression using mouse models.
    Endsley MP; Zhang M
    Methods Enzymol; 2011; 499():149-65. PubMed ID: 21683253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
    Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
    Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
    Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
    Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2.
    Kool J; Hamdi M; Cornelissen-Steijger P; van der Eb AJ; Terleth C; van Dam H
    Oncogene; 2003 Jul; 22(27):4235-42. PubMed ID: 12833146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis.
    Li Z; Shi HY; Zhang M
    Oncogene; 2005 Mar; 24(12):2008-19. PubMed ID: 15688005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
    Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
    Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
    Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
    Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
    Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
    Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ATF-2 in oncogenesis.
    Vlahopoulos SA; Logotheti S; Mikas D; Giarika A; Gorgoulis V; Zoumpourlis V
    Bioessays; 2008 Apr; 30(4):314-27. PubMed ID: 18348191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of X-linked genes in breast cancer.
    Thakur A; Xu H; Wang Y; Bollig A; Biliran H; Liao JD
    Breast Cancer Res Treat; 2005 Sep; 93(2):135-43. PubMed ID: 16187233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
    Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
    Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.